plicamycin has been researched along with sirtinol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiu, PT; Hsiao, G; Hsu, MJ; Hsu, YF; Huang, YH; Kuo, WH; Lin, CH; Ou, G; Sheu, JR; Yang, DS | 1 |
1 other study(ies) available for plicamycin and sirtinol
Article | Year |
---|---|
Trichostatin A and sirtinol suppressed survivin expression through AMPK and p38MAPK in HT29 colon cancer cells.
Topics: AMP-Activated Protein Kinases; Apoptosis; Benzamides; Cell Proliferation; Cell Survival; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Hydroxamic Acids; Inhibitor of Apoptosis Proteins; Luciferases; Naphthols; p38 Mitogen-Activated Protein Kinases; Plicamycin; Promoter Regions, Genetic; Protein Binding; Sp1 Transcription Factor; Survivin; Transcription Factors; Tumor Suppressor Proteins | 2012 |